Recovery of Elective Facial Plastic Surgery in the Post-Coronavirus Disease 2019 Era: Recommendations from the European Academy of Facial Plastic Surgery Task Force.


Journal

Facial plastic surgery & aesthetic medicine
ISSN: 2689-3622
Titre abrégé: Facial Plast Surg Aesthet Med
Pays: United States
ID NLM: 101757922

Informations de publication

Date de publication:
Historique:
pubmed: 15 5 2020
medline: 18 7 2020
entrez: 15 5 2020
Statut: ppublish

Résumé

The impact of the COVID-19 pandemic has resulted in widespread disruption to routine surgical services across the globe. As the peak of the initial pandemic passes, surgeons will increasingly resume elective work to address the backlog. Whilst urgent cases such as cancer work will be prioritized, the safe resumption of facial plastic surgery will remain an ongoing challenge; particularly if there are secondary waves of infection. Rhinoplasty and nasal reconstructive surgery in particular poses a unique challenge to address due to the due to the potential for aerosolizing the virus. A task force of facial plastic surgeons from the European Academy of Facial Plastic Surgery has collaborated to create this document detailing recommendations for resuming a safe facial plastic surgery practice. These include the need to embrace telemedicine, advice on surgical prioritization, planning of clinical area flow plans, advice on pre-/peri- and postoperative care as well as recommendations on training for residents and well-being for surgeons. The recommendations have been made in line with the best available evidence in the literature and are applicable to facial plastic surgery colleagues from around the world in order to resume a safe practice.

Identifiants

pubmed: 32407151
doi: 10.1089/fpsam.2020.0258
doi:

Types de publication

Journal Article Practice Guideline

Langues

eng

Sous-ensembles de citation

IM

Pagination

233-237

Auteurs

Samit N Unadkat (SN)

Charing Cross Hospital, London, United Kingdom.
Royal National ENT and Eastman Dental Hospitals, London, United Kingdom.

Peter J Andrews (PJ)

Royal National ENT and Eastman Dental Hospitals, London, United Kingdom.
Ear Institute, UCL, London, United Kingdom.

Dario Bertossi (D)

Department of Maxillofacial Surgery, G.B. Rossi Hospital and Medical University of Verona, Verona, Italy.

Alwyn D'Souza (A)

Department of Otolaryngology, University Hospital Lewisham, London, United Kingdom.

Anil Joshi (A)

Department of Otolaryngology, University Hospital Lewisham, London, United Kingdom.

Munish Shandilya (M)

The Nose Clinic, Waterford & Dublin, Ireland.

Hesham A Saleh (HA)

Charing Cross Hospital, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH